220 related articles for article (PubMed ID: 21470127)
1. Role of MMPs in metastatic dissemination: implications for therapeutic advances.
Raffo D; Pontiggia O; Simian M
Curr Pharm Biotechnol; 2011 Nov; 12(11):1937-47. PubMed ID: 21470127
[TBL] [Abstract][Full Text] [Related]
2. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
Zucker S; Cao J; Chen WT
Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases: multifunctional contributors to tumor progression.
McCawley LJ; Matrisian LM
Mol Med Today; 2000 Apr; 6(4):149-56. PubMed ID: 10740253
[TBL] [Abstract][Full Text] [Related]
4. The other side of MMPs: protective roles in tumor progression.
Martin MD; Matrisian LM
Cancer Metastasis Rev; 2007 Dec; 26(3-4):717-24. PubMed ID: 17717634
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases: roles in cancer and metastasis.
Fingleton B
Front Biosci; 2006 Jan; 11():479-91. PubMed ID: 16146745
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms to inhibit matrix metalloproteinase activity: where are we in the development of clinically relevant inhibitors?
Corbitt CA; Lin J; Lindsey ML
Recent Pat Anticancer Drug Discov; 2007 Jun; 2(2):135-42. PubMed ID: 18221058
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinases and cancer - roles in threat and therapy.
Yadav L; Puri N; Rastogi V; Satpute P; Ahmad R; Kaur G
Asian Pac J Cancer Prev; 2014; 15(3):1085-91. PubMed ID: 24606423
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase inhibitors.
Ramnath N; Creaven PJ
Curr Oncol Rep; 2004 Mar; 6(2):96-102. PubMed ID: 14751086
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase inhibitors (MMPIs): the beginning of phase I or the termination of phase III clinical trials.
Pavlaki M; Zucker S
Cancer Metastasis Rev; 2003; 22(2-3):177-203. PubMed ID: 12784996
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and tumor metastasis.
Deryugina EI; Quigley JP
Cancer Metastasis Rev; 2006 Mar; 25(1):9-34. PubMed ID: 16680569
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in patent anti-cancer agents targeting the matrix metalloproteinases (MMPs).
Li X; Wu JF
Recent Pat Anticancer Drug Discov; 2010 Jun; 5(2):109-41. PubMed ID: 19951249
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.
Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
Clin Chem Lab Med; 2004 Feb; 42(2):121-31. PubMed ID: 15061349
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinases: biologic activity and clinical implications.
Nelson AR; Fingleton B; Rothenberg ML; Matrisian LM
J Clin Oncol; 2000 Mar; 18(5):1135-49. PubMed ID: 10694567
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase inhibitors and cancer: trials and tribulations.
Coussens LM; Fingleton B; Matrisian LM
Science; 2002 Mar; 295(5564):2387-92. PubMed ID: 11923519
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases in cancer metastasis: molecular targets for prostate cancer prevention by green tea polyphenols and grape seed proanthocyanidins.
Katiyar SK
Endocr Metab Immune Disord Drug Targets; 2006 Mar; 6(1):17-24. PubMed ID: 16611161
[TBL] [Abstract][Full Text] [Related]
16. The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?
Belvisi MG; Bottomley KM
Inflamm Res; 2003 Mar; 52(3):95-100. PubMed ID: 12755372
[TBL] [Abstract][Full Text] [Related]
17. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.
Overall CM; Kleifeld O
Nat Rev Cancer; 2006 Mar; 6(3):227-39. PubMed ID: 16498445
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic implications of the specific inhibition of causative matrix metalloproteinases in experimental colitis induced by dextran sulphate sodium.
Kobayashi K; Arimura Y; Goto A; Okahara S; Endo T; Shinomura Y; Imai K
J Pathol; 2006 Jul; 209(3):376-83. PubMed ID: 16552705
[TBL] [Abstract][Full Text] [Related]
19. Progress in the development of matrix metalloproteinase inhibitors.
Tu G; Xu W; Huang H; Li S
Curr Med Chem; 2008; 15(14):1388-95. PubMed ID: 18537616
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase inhibitors for cancer therapy:the current situation and future prospects.
Fingleton B
Expert Opin Ther Targets; 2003 Jun; 7(3):385-97. PubMed ID: 12783574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
